SCHEMBL9879134

SCHEMBL9879134

C=CCOC(=O)C(N)(CCC)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 3/20 0.44
SCN2A Q99250 3/20 0.44
SCN3A Q9NY46 3/20 0.44
CYP3A4 P08684 3/20 0.44
TSHR P16473 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
NFKB1 P19838 1/20 0.42
MTOR P42345 1/20 0.42
RAB9A P51151 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11783872 0.84 TSHR (0.47) SCN1ASCN2ASCN3ACYP3A4TSHR
SCHEMBL9879540 0.84 CYP3A4 (0.45) SCN1ASCN2ASCN3ACYP3A4TSHR
SCHEMBL22832586 0.80 CYP3A4 (0.50) CYP3A4TSHRALDH1A1HSD17B10LMNA
SCHEMBL3617440 0.79 HTT (0.50) CYP3A4TSHRALDH1A1HSD17B10MEN1
SCHEMBL3617442 0.79 HTT (0.50) CYP3A4TSHRALDH1A1HSD17B10MEN1
SCHEMBL29559663 0.78 TSHR (0.39) SCN1ASCN2ASCN3ACYP3A4TSHR
SCHEMBL6472435 0.78 ALDH1A1 (0.50) SCN1ASCN2ASCN3ACYP3A4TSHR
SCHEMBL7077556 0.78 CYP2C19 (0.42) SCN1ASCN2ASCN3ACYP3A4TSHR
SCHEMBL9879410 0.78 SCN1A (0.40) SCN1ASCN2ASCN3ACYP3A4TSHR
SCHEMBL1502420 0.77 CYP3A4 (0.50) CYP3A4TSHRALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5008285-A Antiarthritic agent with low gastric irritability side effect HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1991-04-16 US disclosed
EP-0159684-B1 (6,11-DIHYDRO-11-OXODIBENZ(B,E)OXEPINYL)PENTANOIC ACIDS AND DERIVATIVES, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-09-27 EP disclosed
EP-0159684-A2 (6,11-Dihydro-11-oxodibenz(b,e)oxepinyl)pentanoic acids and derivatives, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-10-30 EP disclosed